Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A randomized controlled trial on the value of misoprostol for the treatment of retained placenta in a low-resource setting.

van Beekhuizen HJ, Tarimo V, Pembe AB, Fauteck H, Lotgering FK.

Int J Gynaecol Obstet. 2013 Sep;122(3):234-7. doi: 10.1016/j.ijgo.2013.03.029. Epub 2013 Jun 19.

PMID:
23791153
2.

Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania).

van Beekhuizen HJ, Pembe AB, Fauteck H, Lotgering FK.

BMC Pregnancy Childbirth. 2009 Oct 23;9:48. doi: 10.1186/1471-2393-9-48.

3.

No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial.

van Stralen G, Veenhof M, Holleboom C, van Roosmalen J.

Acta Obstet Gynecol Scand. 2013 Apr;92(4):398-403. doi: 10.1111/aogs.12065. Epub 2013 Jan 21.

PMID:
23231499
4.

Prostaglandins for management of retained placenta.

Grillo-Ardila CF, Ruiz-Parra AI, Gaitán HG, Rodriguez-Malagon N.

Cochrane Database Syst Rev. 2014 May 16;(5):CD010312. doi: 10.1002/14651858.CD010312.pub2. Review.

PMID:
24833288
5.
6.

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.

Chaudhuri P, Biswas J, Mandal A.

Int J Gynaecol Obstet. 2012 Feb;116(2):138-42. doi: 10.1016/j.ijgo.2011.09.016. Epub 2011 Nov 17.

PMID:
22100204
7.

A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage.

Fawole AO, Sotiloye OS, Hunyinbo KI, Umezulike AC, Okunlola MA, Adekanle DA, Osamor J, Adeyanju O, Olowookere OO, Adekunle AO, Singata M, Mangesi L, Hofmeyr GJ.

Int J Gynaecol Obstet. 2011 Feb;112(2):107-11. doi: 10.1016/j.ijgo.2010.08.023. Epub 2010 Dec 4.

PMID:
21130446
8.

Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta.

Notten F, Meertens L, Wissink B, Scheepers HC.

Arch Gynecol Obstet. 2014 Jan;289(1):35-40. doi: 10.1007/s00404-013-2919-4. Epub 2013 Jun 15.

PMID:
23771186
9.

Effect of a single preoperative dose of sublingual misoprostol on intraoperative blood loss during total abdominal hysterectomy.

Biswas J, Chaudhuri P, Mandal A, Bandyopadhyay SN, Dasgupta S, Pal A.

Int J Gynaecol Obstet. 2013 Sep;122(3):244-7. doi: 10.1016/j.ijgo.2013.03.025. Epub 2013 Jun 22.

PMID:
23800717
10.

Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.

Chaudhuri P, Majumdar A.

Int J Gynaecol Obstet. 2015 Jan;128(1):48-52. doi: 10.1016/j.ijgo.2014.07.029. Epub 2014 Sep 16.

PMID:
25277789
11.

Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.

Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G.

BMC Pregnancy Childbirth. 2008 Aug 21;8:40. doi: 10.1186/1471-2393-8-40.

12.

Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor.

Hofmeyr GJ, Fawole B, Mugerwa K, Godi NP, Blignaut Q, Mangesi L, Singata M, Brady L, Blum J.

Int J Gynaecol Obstet. 2011 Feb;112(2):98-102. doi: 10.1016/j.ijgo.2010.08.019. Epub 2010 Dec 4.

PMID:
21130990
13.

Misoprostol versus oxytocin for the reduction of postpartum blood loss.

Baskett TF, Persad VL, Clough HJ, Young DC.

Int J Gynaecol Obstet. 2007 Apr;97(1):2-5. Epub 2007 Feb 26.

PMID:
17321529
14.
15.

Nitroglycerin for management of retained placenta.

Abdel-Aleem H, Abdel-Aleem MA, Shaaban OM.

Cochrane Database Syst Rev. 2015 Nov 12;(11):CD007708. doi: 10.1002/14651858.CD007708.pub3. Review.

PMID:
26558329
16.
17.

A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor.

Vaid A, Dadhwal V, Mittal S, Deka D, Misra R, Sharma JB, Vimla N.

Arch Gynecol Obstet. 2009 Dec;280(6):893-7. doi: 10.1007/s00404-009-1019-y. Epub 2009 Mar 11.

PMID:
19277690
18.
19.

Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.

Singh G, Radhakrishnan G, Guleria K.

Int J Gynaecol Obstet. 2009 Nov;107(2):130-4. doi: 10.1016/j.ijgo.2009.06.007. Epub 2009 Jul 22.

PMID:
19628206
20.

A randomised placebo controlled trial of oral misoprostol in the third stage of labour.

Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR.

Br J Obstet Gynaecol. 1998 Sep;105(9):971-5.

PMID:
9763047

Supplemental Content

Support Center